Concepedia

Publication | Open Access

Recovery of phospho-ERK activity allows melanoma cells to escape from BRAF inhibitor therapy

DOIFull Paper Access

309

Citations

25

References

2010

Year

Kim H.T. Paraiso, Inna V. Fedorenko, Liliana Cantini, Ana Cecelia Munko, MacLean Hall, Vernon K. Sondak, Jane L. Messina, Keith T. Flaherty, Keiran S.M. Smalley
British Journal of Cancer

Abstract

Combined BRAF/MEK inhibition may be one strategy to prevent the emergence of drug resistance in BRAF-V600E-mutated melanomas.

References

YearCitations

Page 1